Survey Study on Financial Toxicity for Head and Neck Cancer

(PaRTNer Trial)

Overseen by David Brizel Brizel, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Duke University

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.

Research Team

David Brizel Brizel, MD

Principal Investigator

Duke University Health System (DUHS)

Eligibility Criteria

This study is for adult patients with head and neck cancer (HNC) who are set to undergo radiation therapy, with or without chemotherapy, or surgical resection. Participants must be able to read and write in English and provide informed consent. Those with metastatic disease, recurrent disease, or previous radiation treatments not approved by the principal investigator cannot join.

Inclusion Criteria

Be able to read and write in English

Able to give informed consent and complete survey materials

I am 18 years old or older.

Exclusion Criteria

My cancer has spread to other parts of my body.

My previous radiation treatments must be approved by the study leader before I can join.

My condition has come back after treatment.

Treatment Details

Interventions

• Demographics questionnaires and the FACT HN questionnaire (Behavioural Intervention)

Trial Overview The PaRTNer study is examining the financial burden of HNC treatment on patients. It uses questionnaires to measure out-of-pocket costs and how these expenses affect quality of life and decisions about treatment from the patient's viewpoint during definitive cancer care.

Participant Groups

Group I: Single arm non-therapeutic interventional study Experimental Treatment 1 Intervention

All subjects who enroll on study will be asked to complete questionnaires at baseline before treatment starts; the questionnaires are repeated at one month, three and six months after radiation therapy has been completed. the demographics questionnaire is completed at baseline only; the FACT-HN is completed at all four time points.

Who Is Running the Clinical Trial?

Duke University

Lead Sponsor

Trials

2,495

Recruited

5,912,000+

Mary E. Klotman

Duke University

Chief Executive Officer since 2017

MD from Duke University School of Medicine

Michelle McMurry-Heath

Duke University

Chief Medical Officer since 2020

MD from Duke University School of Medicine